Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1

被引:124
作者
Li, C. [1 ,2 ]
Ao, J. [1 ]
Fu, J. [2 ]
Lee, D-F [3 ]
Xu, J. [2 ]
Lonard, D. [2 ]
O'Malley, B. W. [2 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Mt Sinai Sch Med, Black Family Stem Cell Res Inst, Dept Gene & Cell Med, New York, NY USA
基金
中国国家自然科学基金;
关键词
SRC-3/AIB1; tumor suppressor; SPOP; ubiquitin ligase; steroid receptor co-activator; breast cancer; STEROID-RECEPTOR COACTIVATOR-1; CANCER CELL-PROLIFERATION; REG-GAMMA-PROTEASOME; KINASE-I-EPSILON; F-BOX PROTEINS; BREAST-CANCER; NUCLEAR RECEPTORS; TRANSCRIPTIONAL COACTIVATOR; BETA-CATENIN; E3; LIGASE;
D O I
10.1038/onc.2011.151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroid receptor co-activator-3 (SRC-3/AIB1) is an oncogene that is amplified and overexpressed in many human cancers. However, the molecular mechanisms that regulate 'activated SRC-3 oncoprotein' turnover during tumorigenesis remain to be elucidated. Here, we report that speckle-type POZ protein (SPOP), a cullin 3 (CUL3)-based ubiquitin ligase, is responsible for SRC-3 ubiquitination and proteolysis. SPOP interacts directly with an SRC-3 phospho-degron in a phosphorylation-dependent manner. Casein kinase I epsilon phosphorylates the S102 in this degron and promotes SPOP-dependent turnover of SRC-3. Short hairpin RNA knockdown and overexpression experiments substantiated that the SPOP/CUL3/Rbx1 ubiquitin ligase complex promotes SRC-3 turnover. A systematic analysis of the SPOP genomic locus revealed that a high percentage of genomic loss or loss of heterozygosity occurs at this locus in breast cancers. Furthermore, we demonstrate that restoration of SPOP expression inhibited SRC-3-mediated oncogenic signaling and tumorigenesis, thus positioning SPOP as a tumor suppressor. Oncogene (2011) 30, 4350-4364; doi: 10.1038/onc.2011.151; published online 16 May 2011
引用
收藏
页码:4350 / 4364
页数:15
相关论文
共 70 条
  • [1] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
    Anzick, SL
    Kononen, J
    Walker, RL
    Azorsa, DO
    Tanner, MM
    Guan, XY
    Sauter, G
    Kallioniemi, OP
    Trent, JM
    Meltzer, PS
    [J]. SCIENCE, 1997, 277 (5328) : 965 - 968
  • [2] Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors
    Belandia, B
    Parker, MG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 30801 - 30805
  • [3] Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics
    Bennett, Eric J.
    Rush, John
    Gygi, Steven P.
    Harper, J. Wade
    [J]. CELL, 2010, 143 (06) : 951 - 965
  • [4] Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate
    Bunce, Matthew W.
    Boronenkov, Igor V.
    Anderson, Richard A.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (13) : 8678 - 8686
  • [5] Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
    Chen, HW
    Lin, RJ
    Schiltz, RL
    Chakravarti, D
    Nash, A
    Nagy, L
    Privalsky, ML
    Nakatani, Y
    Evans, RM
    [J]. CELL, 1997, 90 (03) : 569 - 580
  • [6] Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved
    Chen, Miao-Hsueh
    Wilson, Christopher W.
    Li, Ya-Jun
    Lo Law, Kelvin King
    Lu, Chi-Sheng
    Gacayan, Rhodora
    Zhang, Xiaoyun
    Hui, Chi-chung
    Chuang, Pao-Tien
    [J]. GENES & DEVELOPMENT, 2009, 23 (16) : 1910 - 1928
  • [7] Pcif1 modulates Pdxl protein stability and pancreatic β cell function and survival in mice
    Claiborn, Kathryn C.
    Sachdeva, Mira M.
    Cannon, Corey E.
    Groff, David N.
    Singer, Jeffrey D.
    Stoffers, Doris A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (10) : 3713 - 3721
  • [8] Candidate target genes for loss of heterozygosity on human chromosome 17q21
    DeMarchis, L
    Cropp, C
    Sheng, ZM
    Bargo, S
    Callahan, R
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (12) : 2384 - 2389
  • [9] Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites
    Durocher, F
    Tonin, P
    ShattuckEidens, D
    Skolnick, M
    Narod, SA
    Simard, J
    [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (10) : 814 - 819
  • [10] Control of mammalian circadian rhythm by CKIε-regulated proteasome-mediated PER2 degradation
    Eide, EJ
    Woolf, MF
    Kang, H
    Woolf, P
    Hurst, W
    Camacho, F
    Vielhaber, EL
    Giovanni, A
    Virshup, DM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (07) : 2795 - 2807